AngioDynamics, Inc. (ANGO)

AngioDynamics Financials Overview

Financials in millions USD. Fiscal year is June - May.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Revenue Revenue Growth	320.17	320.17	292.5	303.91	338.75	316.22
Revenue Growth	9.46%	9.46%	-3.76%	-10.28%	7.13%	8.66%
Gross Profit Gross Profit Growth	174.89	174.89	157.71	154.7	174.25	165.73
Operating Income Operating Income Growth	-39.93	-39.93	-39.95	-192.44	-51.18	-28.47
Net Income Net Income Growth	-36.74	-36.74	-33.99	-184.35	-52.44	-26.55
Earnings Per Share EPS Growth	-0.88	-0.88	-0.83	-4.59	-1.33	-0.68
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Med Tech Med Tech Growth	149.95	149.95	126.65	106.4	96.69	78.72
Med Device Med Device Growth	170.22	170.22	165.85	197.51	242.07	237.5
Total Total Growth	320.17	320.17	292.5	303.91	338.75	316.22

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Cash & Investments Cash & Investments Growth	53.86	53.86	55.89	76.06	44.62	28.83
Total Debt Total Debt Growth	0	0	0	0	49.82	25
Net Cash (Debt) Net Cash Growth	53.86	53.86	55.89	76.06	-5.2	3.83
Net Cash Growth	-3.63%	-3.63%	-26.51%	-	-	-86.42%
Net Cash Per Share Net Cash Per Share Growth	1.30	1.30	1.37	1.89	-0.13	0.10

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Operating Cash Flow Operating Cash Flow Growth	3.09	3.09	-10.13	-28.16	0.08	-7.19
Capital Expenditures CapEx Growth	-5.95	-5.95	-10.18	-7.53	-9.21	-15.71
Free Cash Flow Free Cash Flow Growth	-2.86	-2.86	-20.31	-35.69	-9.13	-22.9
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 31, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Gross Margin	54.62%	54.62%	53.92%	50.90%	51.44%	52.41%
Operating Margin	-12.47%	-12.47%	-13.66%	-63.32%	-15.11%	-9.00%
Pretax Margin	-11.34%	-11.34%	-11.63%	-63.06%	-16.07%	-9.47%
Profit Margin	-11.48%	-11.48%	-11.62%	-60.66%	-15.48%	-8.40%
FCF Margin	-0.89%	-0.89%	-6.94%	-11.74%	-2.69%	-7.24%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 12, 2026	May 31, 2026	May 31, 2025	May 31, 2024	May 31, 2023	May 31, 2022
Forward PE	-	104.96	104.96	104.96	104.96	287.20
PS Ratio	2.03	1.50	1.43	0.84	1.11	2.43

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error